Clinically, the ATTAIN Phase 3 program showed that orforglipron at its highest dose delivered a mean weight loss of 12.4% over 72 weeks, slightly less than the WEGOVY pills 13.6% at 64 weeks, but with a broader, more diverse patient population of over 3,000 participants
Something else was happening at the level of the blood vessels themselves
Deze prikpennen, zoals die van Ozempic, Wegovy, Saxenda en Mounjaro, zijn gemaakt voor gebruik thuis
References Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030: Consumer Survey commissioned on behalf of Synergy by Suzy LLC and referenced as part of the Carbery Horizon 10 report: Social listening via
GIP receptor agonism Retatrutide activates glucose-dependent insulinotropic polypeptide (GIP) hormone receptors to enhance insulin secretion and glucose reuptake in cells and slow down gastric emptying
Major trends include the rapid growth of the obesity drug segment, the introduction of innovative products like CagriSema and oral GLP-1 agonists, and the continued dominance of North America and Europe, which together account for over 70% of the market share